"REAL-WORLD" USE OF MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN ACADEMIC CENTER

被引：0
|
作者：
Chandrasekhar, Sanjay Amrith
Cornelio, Cyrille
Miranda, Aimon Chantara
Wu, Robby
机构：
[1] Univ S Florida, Tampa, FL USA
[2] Tampa Gen Hosp, Tampa, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1444-135
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [31] Real-World Assessment of Mavacamten's Impact on Left Ventricular Systolic and Diastolic Functions in Obstructive Hypertrophic Cardiomyopathy: A 1-Year Single-Center Observational Study
    Abood, Zaid
    Jan, M. Fuad
    Ashraf, Muddasir
    Hundal, Prabhjot
    Howard, Lauren
    Sanders, Heather
    Misicka, Amanda
    Ghafoor, Asad
    Jahangir, Arshad
    Galazka, Patrycja
    Tajik, A. Jamil
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 242 : 68 - 74
  • [32] Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Scholtz, Smita
    Rudolph, Volker
    Reil, Jan-Christian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [33] Impact of Mavacamten on blood pressure in Hypertrophic Obstructive Cardiomyopathy
    Shehadeh, Mohanad
    Eid, Fahad
    Rahhal, Alaa
    Hanafi, Amir
    Eid, Mohamed
    Baibhav, Bipul
    CIRCULATION, 2024, 150
  • [34] EFFECT OF MAVACAMTEN ON STRAIN PARAMETERS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Hilton, Thomas
    Lewontin, Myra
    Betz, Yaqub
    Higginson, Jason
    Thomas, Matthew J.
    McClean, Karen
    Perry, Allison
    Kramer, Christopher M.
    Ayers, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 757 - 757
  • [35] Atrial Fibrillation Prevalence With Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Jaikumar, Likhitesh
    Biswas, Monodeep
    Kagan, Calvin
    Amara, Richard S.
    Reck, Kim M.
    Shorofsky, Stephen
    Dickfeld, Timm
    Wang, Libin
    See, Vincent Y.
    CIRCULATION, 2023, 148
  • [36] Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy
    Mattia Zampieri
    Alessia Argirò
    Alberto Marchi
    Martina Berteotti
    Mattia Targetti
    Alessandra Fornaro
    Alessia Tomberli
    Pierluigi Stefàno
    Niccolò Marchionni
    Iacopo Olivotto
    Current Cardiology Reports, 2021, 23
  • [37] IMPACT OF GENOTYPE ON MAVACAMTEN RESPONSIVENESS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Giudicessi, John
    Alsidawi, Said
    Geske, Jeffrey Benjamin
    Newman, Darrell Brian
    Arruda-Olson, Adelaide Maria
    Bos, Johan Martijn
    Ommen, Steve R.
    Ackerman, Michael John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 735 - 735
  • [38] Mavacamten improves symptoms in obstructive hypertrophic cardiomyopathy patients
    Zatorski, Nicole
    Sobie, Eric A.
    Schlessinger, Avner
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (05) : 318 - 319
  • [39] Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
    Dong, Tiffany
    Alencherry, Ben
    Ospina, Susan
    Desai, Milind Y.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 1097 - 1106
  • [40] Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy A Clinical Trial
    Heitner, Stephen B.
    Jacoby, Daniel
    Lester, Steven J.
    Owens, Anjali
    Wang, Andrew
    Zhang, David
    Lambing, Joseph
    Lee, June
    Semigran, Marc
    Sehnert, Amy J.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (11) : 741 - +
12345